See also this year's filing and all EDGAR filings for this company.
PDF Report 0001029125_2013_Panbela_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001029125, Panbela Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 336,809 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 15,877 |
| 3 | remainder_Assets | 258,220 |
| 4 | LiabilitiesCurrent | 643,504 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,249 |
| 7 | CostOfGoodsAndServicesSold | 691,802 |
| 8 | SellingGeneralAndAdministrativeExpense | 145,186 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 149,339 |
| 11 | remainder_Revenues | 1,232,704 |
| 12 | remainder_NetIncome | 1,003 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 610,906 |
| 1 | Liabilities | 651,753 |
| 2 | Expenses | 986,327 |
| 3 | Revenues | 1,232,704 |
| 4 | StockholdersEquity | -40,847 |
| 5 | NetIncome | 247,380 |
| 6 | ComprehensiveNetIncome | 247,380 |
| 7 | BaseVar | 1,741,346 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.251 |
| 9 | EconomicCapitalRatio | 1.65 |
Edgar->Model Mapping
Feature Distribution
